Google Search: this blog, links from posts and the web....

Loading...

Monday, February 01, 2010

Patient Advocate Foundation - Executive Board Members

Health-related behavior change after cancer: results of the American Cancer Society’s studies of cancer survivors (SCS)

The Miracle of Vitamin D: Sound Science, or Hype? - Well Blog - NYTimes.com

Drugs A-Z List - A on RxList

This is a useful website for finding a lot of information relating to drugs, including chemotherapies. It includes drug interactions, warnings, generic names, pill identifier, medical dictionary etc. The website has been around for many years.

ACOR in Time Magazine - 'Group Therapy'

Group Therapy - TIME Magazine - ACOR in Time Magazine

full free access: from the series - the Art of Oncology : "Pessimism Is No Poison"

"....The fellow asked the oncologist why he was so pessimistic when talking with the patient. Why did he say things to make the patient and her husband cry? Shouldn't he have given the patient more hope? Would it not have been better for the patient to hear this dire news in chunks over the course of several clinic visits? After all, the patient was so young she may just beat the odds....."

PLoS ONE: Risk of Ovarian Cancer and Inherited Variants in Relapse-Associated Genes

"...We previously reported results of tumor mRNA expression studies which suggested that altered expression of a particular set of genes predicted response to chemotherapy among women with advanced-stage high-grade epithelial ovarian cancer.......Conclusions: "Tumor studies can reveal novel genes worthy of follow-up for cancer susceptibility. Here, we found that inherited markers in the gene encoding MSL1, part of a complex that modifies the histone H4, may decrease risk of invasive serous ovarian cancer."

4th Familial Cancer Conference - Event - ESO


2007 (comparing cancer symptoms) - slide excerpt Benivegna/Pniauskas "Survivors' Debate: The Past Decade in Ovarian Cancer"


Has guideline development gone astray? Yes -- Grol 340: c306 -- BMJ

Has guideline development gone astray? No -- Gibbons et al. 340: c343 -- BMJ

Chemotherapy - MayoClinic - side effects information (general)

MicroRNAs in ovarian carcinomas -- Dahiya and Morin 17 (1): F77 -- Endocrine-Related Cancer

full free access: Duration and magnitude of the postoperative risk of venous thromboembolism in middle aged women: prospective cohort study

Note: the full access to this publication is available for free; professional comments included CONCLUSION: The risk of deep vein thrombosis and pulmonary embolism after surgery is substantially increased in the first 12 postoperative weeks, and varies considerably by type of surgery.

Ovarian Cancer: Your Guide to Taking Control

Reminder: Amazon has copies available

Journal of Experimental & Clinical Cancer Research | Full text | Viscum album L. extracts in breast and gynaecological cancers: a systematic review of clinical and preclinical research

Note: there is a specific section on ovarian cancer

Background: Viscum album L. extracts (VAE, European mistletoe) are a widely used medicinal plant extract in gynaecological and breast-cancer treatment.  Conclusion: VAE shows some positive effects in breast and gynaecological cancer. More research into clinical efficacy is warranted.

Use of CT Scans Linked to Cancer Risk, Studies Say | netReturns | e-Newsletter

"There is considerable disagreement in the scientific community about the validity of these models," notes Rosaleen Parsons, M.D., chair of the department of diagnostic imaging at Fox Chase Cancer Center. "And some scientists believe the radiation dose from these CT scans may not lead to any increased risk of cancer."

In the second study, conducted at the University of California-San Francisco, researchers compared CT scan use at four San Francisco Bay area facilities. They found that the amount of radiation from a CT scan may be up to four times greater than estimated in previous studies. In addition, they noted significant differences among different institutions and, in some instances, within the same institution, when looking at the radiation dose associated with CT scans.